These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2191426)

  • 1. Biosafety considerations in industries with production methods based on the use of recombinant deoxyribonucleic acid.
    Andrup L; Nielsen BH; Kølvraa S
    Scand J Work Environ Health; 1990 Apr; 16(2):85-95. PubMed ID: 2191426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental concerns associated with the design of genetic engineering facilities.
    Watt JC; Wroniewicz VS; Ioli DF
    Basic Life Sci; 1988; 45():307-22. PubMed ID: 3178641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting researchers from instrument biohazards.
    Hambleton P; Dedonato G
    Biotechniques; 1992 Sep; 13(3):450-3. PubMed ID: 1389178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisit NIH biosafety guidelines.
    Oye KA; O'Leary M; Riley MF
    Science; 2017 Aug; 357(6352):627. PubMed ID: 28818918
    [No Abstract]   [Full Text] [Related]  

  • 5. Federal Law of 5 June 1996 on state regulation in the field of genetic engineering activities.
    Russian Federation
    Int Dig Health Legis; 1998; 49(3):529-32. PubMed ID: 11657542
    [No Abstract]   [Full Text] [Related]  

  • 6. The promise and perils of synthetic biology.
    Tucker JB; Zilinskas RA
    New Atlantis; 2006; 12():25-45. PubMed ID: 16832953
    [No Abstract]   [Full Text] [Related]  

  • 7. Proposals involving field testing of recombinant DNA containing organisms.
    Milewski E; Talbot B
    Recomb DNA Tech Bull; 1983 Dec; 6(4):141-5. PubMed ID: 6582539
    [No Abstract]   [Full Text] [Related]  

  • 8. Fate of genetically-engineered microbes in natural environments.
    Stotzky G; Babich H
    Recomb DNA Tech Bull; 1984 Dec; 7(4):163-88. PubMed ID: 6100330
    [No Abstract]   [Full Text] [Related]  

  • 9. Models of genetically engineered organisms and their ecological impact.
    Regal PJ
    Recomb DNA Tech Bull; 1987 Sep; 10(3):67-85. PubMed ID: 3317526
    [No Abstract]   [Full Text] [Related]  

  • 10. Biocontainment design considerations for biopharmaceutical facilities.
    Miller SR; Bergmann D
    J Ind Microbiol; 1993 Jul; 11(4):223-34. PubMed ID: 7763894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recombinant strains: their biological properties and the safety measures in working with them].
    Vorob'ev AA; Khoroshko NV; Selezneva OIu
    Vestn Ross Akad Med Nauk; 1993; (2):31-7. PubMed ID: 7688617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second International Symposium on the Biosafety Results of Genetically Modified Plants and Microorganisms. May 1992, Goslar, FRG.
    Millis NF
    Australas Biotechnol; 1992 Aug; 2(4):237-9. PubMed ID: 1368823
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant DNA technology: a 20-year occupational health retrospective.
    Cohen R; Hoerner CL
    Rev Environ Health; 1996; 11(3):149-65. PubMed ID: 9000305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosafety considerations in handling medically important fungi.
    Padhye AA; Bennett JE; McGinnis MR; Sigler L; Fliss A; Salkin IF
    Med Mycol; 1998; 36 Suppl 1():258-65. PubMed ID: 9988515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research with recombinant DNA: potential risks, potential benefits, and ethical considerations.
    Kukin M
    N Y State J Med; 1978 Feb; 78(2):226-35. PubMed ID: 11661561
    [No Abstract]   [Full Text] [Related]  

  • 16. The dual-use conundrum.
    Berg P
    Science; 2012 Sep; 337(6100):1273. PubMed ID: 22984033
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioengineering hazards.
    Becker J
    Nature; 1981 May; 291(5812):181. PubMed ID: 6112712
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recombinant DNA and genetic manipulation, reality and fantasy (author's transl)].
    Winkler KC
    Tijdschr Diergeneeskd; 1982 Jan; 107(1):4-11. PubMed ID: 6275569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene technology and biological safety].
    Hahlbrock K
    Naturwissenschaften; 1989 Dec; 76(12):560-4. PubMed ID: 2695846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
    Krimsky S
    Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.